NASDAQ:UTMD - Utah Medical Products Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$111.50 -1.85 (-1.63 %)
(As of 06/22/2018 11:24 AM ET)
Previous Close$111.50
Today's Range$111.50 - $111.50
52-Week Range$68.10 - $116.95
Volume12 shs
Average Volume15,347 shs
Market Capitalization$432.74 million
P/E Ratio28.64
Dividend Yield0.93%
Beta0.6
Utah Medical Products logoUtah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and UTMD supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:UTMD
CUSIP91748810
Phone801-566-1200

Debt

Debt-to-Equity RatioN/A
Current Ratio10.37
Quick Ratio9.29

Price-To-Earnings

Trailing P/E Ratio28.64
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$41.41 million
Price / Sales10.04
Cash Flow$4.4779 per share
Price / Cash24.90
Book Value$21.00 per share
Price / Book5.31

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$8.50 million
Net Margins21.56%
Return on Equity18.94%
Return on Assets16.50%

Miscellaneous

Employees183
Outstanding Shares3,730,000

Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a dividend on Tuesday, May 8th. Investors of record on Friday, June 15th will be given a dividend of $0.27 per share on Thursday, June 7th. The ex-dividend date is Thursday, June 14th. View Utah Medical Products' Dividend History.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings data on Thursday, April, 26th. The medical instruments supplier reported $1.09 earnings per share for the quarter. The medical instruments supplier had revenue of $10.89 million for the quarter. Utah Medical Products had a return on equity of 18.94% and a net margin of 21.56%. View Utah Medical Products' Earnings History.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for Utah Medical Products.

Who are some of Utah Medical Products' key competitors?

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the folowing people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 71)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

Has Utah Medical Products been receiving favorable news coverage?

Media stories about UTMD stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Utah Medical Products earned a media sentiment score of 0.16 on Accern's scale. They also gave news stories about the medical instruments supplier an impact score of 45.81 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (4.52%), WCM Investment Management CA (2.20%), Ancora Advisors LLC (2.13%), Russell Investments Group Ltd. (2.11%), JPMorgan Chase & Co. (0.73%) and Wells Fargo & Company MN (0.60%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Ernst G Hoyer and Kevin L Cornwell. View Institutional Ownership Trends for Utah Medical Products.

Which major investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including Morgan Dempsey Capital Management LLC, Wells Fargo & Company MN, JPMorgan Chase & Co., Bailard Inc., Citigroup Inc., WCM Investment Management CA and Wedge Capital Management L L P NC. Company insiders that have sold Utah Medical Products company stock in the last year include Barbara A Payne, Ernst G Hoyer and Kevin L Cornwell. View Insider Buying and Selling for Utah Medical Products.

Which major investors are buying Utah Medical Products stock?

UTMD stock was acquired by a variety of institutional investors in the last quarter, including Ancora Advisors LLC, Russell Investments Group Ltd., Dimensional Fund Advisors LP, California Public Employees Retirement System, Barclays PLC, Schwab Charles Investment Management Inc., Prudential Financial Inc. and UBS Group AG. View Insider Buying and Selling for Utah Medical Products.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $111.50.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $432.74 million and generates $41.41 million in revenue each year. Utah Medical Products employs 183 workers across the globe.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.


MarketBeat Community Rating for Utah Medical Products (UTMD)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  166
MarketBeat's community ratings are surveys of what our community members think about Utah Medical Products and other stocks. Vote "Outperform" if you believe UTMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UTMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.